Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Surveillance of RTS,S/AS01E Malaria Vaccine in African Children (MALARIA-076)
NCT02207816Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2014
- Primary completion
- Jan 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of RTS,S in malaria, sponsored by GSK. Started Sep 2014; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02207816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02207816.